Re: Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib
- PMID: 21862728
- DOI: 10.1093/jnci/djr328
Re: Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib
Comment on
-
Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.J Natl Cancer Inst. 2011 May 4;103(9):763-73. doi: 10.1093/jnci/djr128. Epub 2011 Apr 28. J Natl Cancer Inst. 2011. PMID: 21527770 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
